| Application no. and date | 11715042.5 (espacenet) (Federated) (European Patent Register), 20110321 | | Patent/reg. no. and date | DK/EP 2558447, 20140917 | | Publication date | 20130220 | | Priority no. and date | WO PCT/IB2010/051228, 20100322 | | EP pub. no. and date |
EP 2558447 20130220 | | Effective date | | | Applicant/owner | Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91
4123 Allschwil, CH | | Applicant ref. no. | P54870dk01 | | Inventor | AISSAOUI, Hamed, c/o Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
CH-4123 Allschwil, CH,
SIEGRIST, Romain, c/o Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
CH-4123 Allschwil, CH,
RICHARD-BILDSTEIN, Sylvia, c/o Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
CH-4123 Allschwil, CH,
FRETZ, Heinz, c/o Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
CH-4123 Allschwil, CH,
HAZEMANN, Julien, c/o Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
CH-4123 Allschwil, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/403 (2006.01) , A61P 11/06 (2006.01) , C07D 209/88 (2006.01) | | Title | 3-(HETEROARYL-AMINO)-1,2,3,4-TETRAHYDRO-9H-CARBAZOLDERIVATER OG DERES ANVENDELSE SOM PROSTAGLANDIN D2-RECEPTORMODULATORER | | Int. application no. | IB2011051165 | | Int. publication no. | WO2011117798 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
